Ertugliflozin L-pyroglutamic acid

Overview

Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 ( SGLT2 ), with an IC 50 of 0.877 nM for h-SGLT2. Has the potential for the treatment of type 2 diabetes mellitus.

Application

Products | Products > Disease Areas > Obesity | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > SGLT

Product Information

• Catalog No.: HY-15461A
• CAS No.: 1210344-83-4
• Molecular Formula: C27H32ClNO10
• Molecular Weight: 566.00
• Purity: 99.84%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.08 mg/mL (3.67 mM); Clear solution
• Availability: In-stock

Source

Original product source